Healsun Biopharm started its journey by providing stable cell line construction services and has gradually expanded its scope of services to one-stop R&D and production solution for antibodies, fusion proteins, and ADC products from early druggability evaluation, IND pharmaceutical research to commercial production.
After years of dedicated efforts, we have garnered the trust and loyalty of numerous esteemed clients through our excellent service and reputation. We aspire to become a leading CDMO service provider, aiming to provide our clients with the highest quality solutions and support them in achieving remarkable accomplishments in the field of drug development.
Providing clients with comprehensive molecular design and evaluation service, such as protein engineering, activity analysis and druggability analysis based on our high-quality protein production platforms and multiple analytical tools
Self-developed HaoYue® Platform, which can deliver sublicensable stable cell lines with high expression
Process development platforms
2*250 L/500 L GMP manufacturing lines for DS and DP
100 L GMP manufacturing line for ADC DS
6*2000 L commercial-scale manufacturing lines for antibodies
500 L commercial-scale manufacturing line for ADC products
2015
Founded
52500 m²
Area
4
Sites
250+
Employees